972 related articles for article (PubMed ID: 27553758)
1. HMGB1 and thrombin mediate the blood-brain barrier dysfunction acting as biomarkers of neuroinflammation and progression to neurodegeneration in Alzheimer's disease.
Festoff BW; Sajja RK; van Dreden P; Cucullo L
J Neuroinflammation; 2016 Aug; 13(1):194. PubMed ID: 27553758
[TBL] [Abstract][Full Text] [Related]
2. Blood-Brain Barrier Dysfunction and the Pathogenesis of Alzheimer's Disease.
Yamazaki Y; Kanekiyo T
Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28902142
[TBL] [Abstract][Full Text] [Related]
3. The Relationship between Markers of Inflammation and Degeneration in the Central Nervous System and the Blood-Brain Barrier Impairment in Alzheimer's Disease.
Muszyński P; Kulczyńska-Przybik A; Borawska R; Litman-Zawadzka A; Słowik A; Klimkowicz-Mrowiec A; Pera J; Dziedzic T; Mroczko B
J Alzheimers Dis; 2017; 59(3):903-912. PubMed ID: 28697565
[TBL] [Abstract][Full Text] [Related]
4. Anti-RAGE antibody attenuates isoflurane-induced cognitive dysfunction in aged rats.
Shi C; Yi D; Li Z; Zhou Y; Cao Y; Sun Y; Chui D; Guo X
Behav Brain Res; 2017 Mar; 322(Pt A):167-176. PubMed ID: 28115220
[TBL] [Abstract][Full Text] [Related]
5. Blood-Brain Barrier Breakdown in Relationship to Alzheimer and Vascular Disease.
Lin Z; Sur S; Liu P; Li Y; Jiang D; Hou X; Darrow J; Pillai JJ; Yasar S; Rosenberg P; Albert M; Moghekar A; Lu H
Ann Neurol; 2021 Aug; 90(2):227-238. PubMed ID: 34041783
[TBL] [Abstract][Full Text] [Related]
6. Anti-high mobility group box-1 monoclonal antibody protects the blood-brain barrier from ischemia-induced disruption in rats.
Zhang J; Takahashi HK; Liu K; Wake H; Liu R; Maruo T; Date I; Yoshino T; Ohtsuka A; Mori S; Nishibori M
Stroke; 2011 May; 42(5):1420-8. PubMed ID: 21474801
[TBL] [Abstract][Full Text] [Related]
7. Proximate Mediators of Microvascular Dysfunction at the Blood-Brain Barrier: Neuroinflammatory Pathways to Neurodegeneration.
Festoff BW; Sajja RK; Cucullo L
Biomed Res Int; 2017; 2017():1549194. PubMed ID: 28890893
[TBL] [Abstract][Full Text] [Related]
8. Electroacupuncture Improves Blood-Brain Barrier and Hippocampal Neuroinflammation in SAMP8 Mice by Inhibiting HMGB1/TLR4 and RAGE/NADPH Signaling Pathways.
Wang Y; Wang Q; Luo D; Zhao P; Zhong SS; Dai B; Wang JJ; Wan YT; Liu ZB; Yang H
Chin J Integr Med; 2023 May; 29(5):448-458. PubMed ID: 36609953
[TBL] [Abstract][Full Text] [Related]
9. Plasma neuronal exosomes serve as biomarkers of cognitive impairment in HIV infection and Alzheimer's disease.
Pulliam L; Sun B; Mustapic M; Chawla S; Kapogiannis D
J Neurovirol; 2019 Oct; 25(5):702-709. PubMed ID: 30610738
[TBL] [Abstract][Full Text] [Related]
10. AGE-RAGE stress: a changing landscape in pathology and treatment of Alzheimer's disease.
Prasad K
Mol Cell Biochem; 2019 Sep; 459(1-2):95-112. PubMed ID: 31079281
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-107 prevents amyloid-beta induced blood-brain barrier disruption and endothelial cell dysfunction by targeting Endophilin-1.
Liu W; Cai H; Lin M; Zhu L; Gao L; Zhong R; Bi S; Xue Y; Shang X
Exp Cell Res; 2016 May; 343(2):248-257. PubMed ID: 27038654
[TBL] [Abstract][Full Text] [Related]
12. Blood-brain barrier dysfunction underlying Alzheimer's disease is induced by an SSAO/VAP-1-dependent cerebrovascular activation with enhanced Aβ deposition.
Solé M; Esteban-Lopez M; Taltavull B; Fábregas C; Fadó R; Casals N; Rodríguez-Álvarez J; Miñano-Molina AJ; Unzeta M
Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2189-2202. PubMed ID: 31047972
[TBL] [Abstract][Full Text] [Related]
13. EGb761 provides a protective effect against Aβ1-42 oligomer-induced cell damage and blood-brain barrier disruption in an in vitro bEnd.3 endothelial model.
Wan WB; Cao L; Liu LM; Kalionis B; Chen C; Tai XT; Li YM; Xia SJ
PLoS One; 2014; 9(11):e113126. PubMed ID: 25426944
[TBL] [Abstract][Full Text] [Related]
14. Neurovascular mechanisms of Alzheimer's neurodegeneration.
Zlokovic BV
Trends Neurosci; 2005 Apr; 28(4):202-8. PubMed ID: 15808355
[TBL] [Abstract][Full Text] [Related]
15. Dysfunction of the blood-brain barrier in Alzheimer's disease: Evidence from human studies.
Kurz C; Walker L; Rauchmann BS; Perneczky R
Neuropathol Appl Neurobiol; 2022 Apr; 48(3):e12782. PubMed ID: 34823269
[TBL] [Abstract][Full Text] [Related]
16. Surgery upregulates high mobility group box-1 and disrupts the blood-brain barrier causing cognitive dysfunction in aged rats.
He HJ; Wang Y; Le Y; Duan KM; Yan XB; Liao Q; Liao Y; Tong JB; Terrando N; Ouyang W
CNS Neurosci Ther; 2012 Dec; 18(12):994-1002. PubMed ID: 23078219
[TBL] [Abstract][Full Text] [Related]
17. Role of Blood-Brain Barrier in Alzheimer's Disease.
Cai Z; Qiao PF; Wan CQ; Cai M; Zhou NK; Li Q
J Alzheimers Dis; 2018; 63(4):1223-1234. PubMed ID: 29782323
[TBL] [Abstract][Full Text] [Related]
18. Amyloid Beta 25-35 induces blood-brain barrier disruption in vitro.
Cuevas E; Rosas-Hernandez H; Burks SM; Ramirez-Lee MA; Guzman A; Imam SZ; Ali SF; Sarkar S
Metab Brain Dis; 2019 Oct; 34(5):1365-1374. PubMed ID: 31267346
[TBL] [Abstract][Full Text] [Related]
19. HMGB1 Release Induced by EV71 Infection Exacerbates Blood-Brain Barrier Disruption via VE-cadherin Phosphorylation.
You Q; Wu J; Liu Y; Zhang F; Jiang N; Tian X; Cai Y; Yang E; Lyu R; Zheng N; Chen D; Wu Z
Virus Res; 2023 Dec; 338():199240. PubMed ID: 37832655
[TBL] [Abstract][Full Text] [Related]
20. Impact of HMGB1, RAGE, and TLR4 in Alzheimer's Disease (AD): From Risk Factors to Therapeutic Targeting.
Paudel YN; Angelopoulou E; Piperi C; Othman I; Aamir K; Shaikh MF
Cells; 2020 Feb; 9(2):. PubMed ID: 32046119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
